EAACI Congress 2024
Conozca los últimos avances en Alergia e Inmunología Clínica en el Congreso EAACI 2024, Valencia, España https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, España, March 19, 2024 (GLOBE NEWSWIRE) -- EAACI, Agencia Europea de Alergia e Inmunología...
EAACI Congress 2024
2024 EAACI 학술대회, 알레르기 및 임상 면역학의 최신 동향을 주제로 스페인 발렌시아에서 개최 https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 발렌시아, 스페인, March 19, 2024 (GLOBE NEWSWIRE) -- 전 세계 125개국에서 1만 6천 명 이상의 회원을 보유한 유럽 알레르기 임상 면역학회(European...
EAACI Congress 2024
アレルギーと臨床免疫学の最新動向を、スペイン、バレンシアで開催される「EAACI Congress 2024」で網羅 http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 スペイン、バレンシア発, March 19, 2024 (GLOBE NEWSWIRE) --...
EAACI Congress 2024
ההתפתחויות האחרונות באלרגיה ואימונולוגיה קלינית ייסקרו בקונגרס EAACI 2024 בוולנסיה, ספרד http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 ולנסיה, ספרד, March 19, 2024 (GLOBE NEWSWIRE) -- האקדמיה האירופית לאלרגיה ואימונולוגיה קלינית - The...
EAACI Congress 2024
Informieren Sie sich über die neuesten Entwicklungen auf dem Gebiet der Allergie und klinischen Immunologie auf dem EAACI-Kongress 2024 in Valencia, Spanien http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spanien, March 19, 2024 (GLOBE NEWSWIRE) -- Die Europäische Akademie für Allergologie und...
EAACI Congress 2024
Couvrez les derniers développements en matière d'allergie et d'immunologie clinique lors du Congrès 2024 de l'EAACI à Valence en Espagne http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCE, Espagne, 19 mars 2024 (GLOBE NEWSWIRE) -- L'European Academy of Allergy and Clinical Immunology...
EAACI Congress 2024
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical...
Sema4_Logo2021_Primary_Gradient.png
Sema4 to Participate at Two Investor Conferences in June 2022
26 mai 2022 08h00 HE | Sema4
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 mai 2022 16h05 HE | Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
02 mai 2022 07h45 HE | Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...